Evofem Biosciences, Inc. (EVFM) Social Stream
EVOFEM BIOSCIENCES INC (EVFM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EVFM.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-10-21 | 4 | $5 | $0.8 | $3.075 | $0.478 | 543.31% |
2021-12-15 | 4 | $2 | $0.75 | $1.687 | $0.478 | 252.93% |
2022-01-31 | 4 | $3 | $0.75 | $1.937 | $0.478 | 305.23% |
2022-03-03 | 4 | $3 | $0.5 | $1.875 | $0.478 | 292.26% |
2022-04-12 | 4 | $3 | $0.57 | $1.892 | $0.478 | 295.82% |
2022-05-05 | 4 | $44.977 | $8.545 | $28.373 | $0.478 | 5835.77% |
2022-05-09 | 4 | $44.977 | $2 | $26.736 | $0.478 | 5493.31% |
2022-05-25 | 4 | $44.977 | $2 | $19.74 | $0.478 | 4029.71% |
2022-06-02 | 4 | $44.977 | $2 | $16.492 | $0.478 | 3350.21% |
2022-08-04 | 4 | $29.985 | $0.75 | $7.847 | $0.478 | 1541.63% |
2022-08-16 | 4 | $4 | $0.75 | $2.65 | $0.478 | 454.39% |
EVFM reports an average of 2,389.29% for its upside potential over the past 43 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-01-13 | 4 | 3.000 | 0.750 | 1.937 | 0.395 | 390.38% |
2022-03-03 | 4 | 3.000 | 0.530 | 1.882 | 0.490 | 284.08% |
2022-03-03 | 4 | 3.000 | 0.500 | 1.875 | 0.490 | 282.65% |
2022-05-05 | 4 | 44.977 | 8.545 | 28.373 | 0.110 | 25693.64% |
2022-08-16 | 4 | 4.000 | 0.750 | 2.650 | 0.478 | 454.39% |
EVFM Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.83 | 3 | 0 | 0 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
EVFM's average broker recommendation rating improved by 0 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVFM as an investment opportunity.
- EVFM has a lower variance in analysts' estimates than -1033.13% of all US stocks.
- EVOFEM BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 1128.61% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, EVOFEM BIOSCIENCES INC's average analyst price target is higher than 122.06% of them.
- EVFM has a greater number of analysts covering the stock than 261% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to EVOFEM BIOSCIENCES INC are ETON, EQ, and ENVB.
View All Top Stocks by Price Target
Is EVFM a Buy, Hold or Sell? See the POWR Ratings now!